IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Translational Medicine"
DOI: 10.1186/s12967-022-03275-0
Abstract: Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer (GC); however, the underlying mechanism remains unknown. Methods This study determined the expression of IRF-2 in GC tissues and adjacent non-tumor tissues… read more here.
Keywords: cancer; tumor; irf; proliferation ... See more keywords